Clinicians often face uncertainty about whether they can rely on a negative chest x-ray (CXR) to rule out pneumonia in a child, even when other clinical signs and symptoms may have raised that concern ...
OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced that its latest research has been accepted for poster presentation at the ...
Objective To review the sensitivity and specificity of the proposed international consensus on-field visible signs of concussion in a cohort of National Rugby League (NRL) players. Design Prospective ...
Human epidermal growth factor receptor 2 (HER2) overexpression is present in about 3% to 5% of cases of metastatic colorectal cancer. HER2 is a well-established negative predictive biomarker in ...
Clinical Presentation and Outcomes of Patients With Cancer-Associated Isolated Distal Deep Vein Thrombosis Previously untreated patients with MCL age 60 years or older have been randomly assigned to R ...
A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...
Yanru Qiao, Christina A. Spivey, Junling Wang, Ya-Chen Tina Shih, Jim Y. Wan, Julie Kuhle, Samuel Dagogo-Jack, William C. Cushman, Marie A. Chisholm-Burns https://www ...
The blood-based biomarker test measures Tau protein phosphorylated at threonine 181 in human plasma (pTau181).
A recent study supports the notion that non–driver mutations in essential thrombocythemia (ET) and polycythemia vera (PV) have predictive value and found that a proposed international prognostication ...
Acorai, a clinical-stage company pioneering non-invasive hemodynamic monitoring for heart failure management, this week ...
Researchers with the New York City Health Department say the results suggest real-time veterinary surveillance for carbapenem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback